PFIZER INC 8-K

What Happened

• Pfizer Inc. filed an 8-K on April 27, 2026 reporting results of its Annual Meeting of Shareholders held April 23, 2026. All director nominees listed in the company’s March 12, 2026 proxy were elected to the Board. KPMG LLP was ratified as Pfizer’s independent registered public accounting firm for 2026. The Pfizer Inc. 2019 Stock Plan (as amended April 2026) and the advisory vote on 2026 executive compensation were approved. A shareholder proposal to adopt an independent chair policy was not approved.

Key Details

• Board elections: all nominees elected; sample vote totals include Cyrus Taraporevala (For: 3,468,177,423; Against: 76,665,721), James Quincey (For: 3,453,778,741; Against: 91,549,236) and Joseph J. Echevarria had the largest Against total among nominees (For: 2,929,511,380; Against: 612,413,502). Broker non-votes on director elections: 941,392,137.
• Auditor ratification: KPMG LLP ratified (For: 4,160,827,231; Against: 321,979,096; Abstentions: 15,214,720).
• Stock plan: Pfizer Inc. 2019 Stock Plan, as amended April 2026, approved (For: 3,227,692,578; Against: 305,428,376; Abstentions: 23,507,956; Broker non-votes: 941,392,137).
• Say-on-pay (advisory): 2026 named executive officer compensation approved (For: 3,099,249,442; Against: 423,935,881; Abstentions: 33,443,287).
• Shareholder proposal to adopt an independent chair policy failed (For: 1,015,206,372; Against: 2,509,042,021; Abstentions: 32,354,566).

Why It Matters

• The results confirm Pfizer’s board slate and auditors for 2026, and approval of the amended stock plan preserves equity compensation capacity the company can use for retention and incentives. The advisory approval of executive compensation (non-binding) signals shareholder support for pay practices this year. The rejection of an independent-chair policy means Pfizer’s shareholders did not adopt a governance change to require a board chair who is independent. High broker non-vote totals on certain matters reflect shares held by brokers that were not voted on some proposals, which can affect the voting dynamics for contested or shareholder-sponsored items.